about
Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.Endothelial cell metabolism and implications for cancer therapy.Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective?To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!Immunotherapy: Burning fences.Metabolism: Fusion power.Gastric cancer: Risk analysis.Endothelial Cell Metabolism.Metabolism: Conscious decoupling.Non-small cell lung cancer: Where there's smoke...Tumour angiogenesis: Controlling nerves.Metabolism: More lactate, please.Leukaemia: Beyond the C.Cancer: Ironing it out.Pap seeking new challenges.Therapeutic resistance: Ironing it out.Metastasis: Throwing oil into the flames.Endothelial Barrier and Metabolism: New Kids on the Block Regulating Bone Marrow Vascular NichesBETting on YAP-TAZOncogenic mRNA modification explainedCAR antigens beyond recognitionQuiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox HomeostasisBreast cancer: Staying silentImmunotherapy: Tear down this wallImmunotherapy: Tear down this wallImmunosurveillance: Presentation skillsBreast cancer: External communicationOn the cutting edgeTumour vaccines: Personal training by vaccinationCancer: Beyond the CSuccess storiesFrom rock 'n' roll to heavy metalA source of calciumThe sugar loopMaintaining the tumour's dietEpigenetic control by sugarSenolytic helpersPlatelets with dangerous cargoE-selectin fills two needs for metastasis
P50
Q34044783-C0594C42-754C-4719-A604-139835918FC4Q37654522-8C21520B-EF7D-4B34-9571-AAD5B399DD2CQ38050680-F203FE43-E1FD-42EA-89CD-2E86C03D21A1Q38882106-05E741CF-CFD8-4989-A347-5A4307916E35Q44207301-4F315176-44D2-4686-A023-A8E7638B9D8FQ49385654-5BFC2521-21A8-4663-B853-953F4C48D59CQ49716325-A0BD5C34-0D8D-4F29-9C64-3A71ED98D3ECQ49716363-44230FF9-D341-4C38-AC51-7F3C938E4110Q49787990-2BA60E9D-E1F6-446C-8E9C-02467DFB83E0Q49833417-478BBF18-E346-47F3-A62A-6EDA3F3C17E9Q50061837-883C8A61-5D26-456D-9549-DA7BC47DB577Q50082402-36490C43-173E-4ED1-BA28-C8F826AAD1ADQ50096908-C77A17A1-4EAE-4BA4-9AC1-FFE2B3AEB839Q50202569-3351248D-D429-41D8-9D08-8EB54480D30EQ50240107-14696380-5AAF-4D19-8B9F-8398DC02C82EQ52564852-4D9277DF-F111-49D3-93DB-E6EF7F3B4166Q53729507-550433F9-D46B-4090-AD05-E67809A98373Q53784252-2ABA62F8-1163-4BFE-8BEA-F3ED06D1699BQ56777580-9D226946-2394-4AC9-95BE-34FB3CE57F13Q57291582-55FF54E4-2A0E-4CE4-84EE-0A9258BBC908Q57476560-33D65FFD-E676-4A1E-81C4-6BB1A287FD5DQ58561244-8D69081A-ACD1-4B97-9FCF-7B905ED52E34Q61821529-30287114-D4B3-4C8E-BE64-282F4F6BC198Q87842570-7649006F-BD7D-406A-86F4-A832AB7FC6A4Q88007956-A5AB5601-AB2C-42B0-9A1B-454B1B5B5B6BQ88073791-3D72CAA9-2D82-4DC0-ADA8-10319043A342Q88125389-56492A5F-905D-4B69-81F3-91938E5CAADDQ88249543-454D5529-E06D-4B4A-B3CE-2C2B6BCB82B9Q88525048-05162926-459C-464E-9E38-9C832FEEB9F9Q88594744-B129C2D0-6D09-4CBB-BC2B-9A134B376B07Q89098899-FE9495C3-158D-49FE-B8FE-5DBBFAAC8708Q89207531-53BA9099-B832-4E82-B895-C1780574EFE5Q89326589-970AD345-0A12-468D-9A65-65B3103C0821Q90227818-ED60080C-0A50-4FC3-8941-3796314062DDQ90724679-405B2142-E3B9-4A40-AFBA-8627EA45B302Q90893911-704E1D2F-B829-43F5-BB15-E9A844389EC1Q91211080-0BF21975-821C-4ACC-8AAA-657D605786C3Q91361590-3EAD6592-785E-43A9-A595-8605AAD8EFCCQ91624451-B2DA7D7B-B991-435C-BA63-6480FD46DFB1Q91833905-98D38AF9-D9C5-495E-8F9E-A147B8794D90
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ulrike Harjes
@ast
Ulrike Harjes
@en
Ulrike Harjes
@es
Ulrike Harjes
@nl
type
label
Ulrike Harjes
@ast
Ulrike Harjes
@en
Ulrike Harjes
@es
Ulrike Harjes
@nl
prefLabel
Ulrike Harjes
@ast
Ulrike Harjes
@en
Ulrike Harjes
@es
Ulrike Harjes
@nl
P106
P31
P496
0000-0003-0376-1262